Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP707166.RAFVtgX2WTdSfkUiM0QssSJzkbkf9nm7-7K8RmHnP_Pgo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP707166.RAFVtgX2WTdSfkUiM0QssSJzkbkf9nm7-7K8RmHnP_Pgo130_assertion type Assertion NP707166.RAFVtgX2WTdSfkUiM0QssSJzkbkf9nm7-7K8RmHnP_Pgo130_head.
- NP707166.RAFVtgX2WTdSfkUiM0QssSJzkbkf9nm7-7K8RmHnP_Pgo130_assertion description "[Sod2 reduction decreased amyloid plaques in the brain parenchyma but promoted the development of cerebrovascular amyloidosis, gliosis, and plaque-independent neuritic dystrophy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP707166.RAFVtgX2WTdSfkUiM0QssSJzkbkf9nm7-7K8RmHnP_Pgo130_provenance.
- NP707166.RAFVtgX2WTdSfkUiM0QssSJzkbkf9nm7-7K8RmHnP_Pgo130_assertion evidence source_evidence_literature NP707166.RAFVtgX2WTdSfkUiM0QssSJzkbkf9nm7-7K8RmHnP_Pgo130_provenance.
- NP707166.RAFVtgX2WTdSfkUiM0QssSJzkbkf9nm7-7K8RmHnP_Pgo130_assertion SIO_000772 16687508 NP707166.RAFVtgX2WTdSfkUiM0QssSJzkbkf9nm7-7K8RmHnP_Pgo130_provenance.
- NP707166.RAFVtgX2WTdSfkUiM0QssSJzkbkf9nm7-7K8RmHnP_Pgo130_assertion wasDerivedFrom befree-20150227 NP707166.RAFVtgX2WTdSfkUiM0QssSJzkbkf9nm7-7K8RmHnP_Pgo130_provenance.
- NP707166.RAFVtgX2WTdSfkUiM0QssSJzkbkf9nm7-7K8RmHnP_Pgo130_assertion wasGeneratedBy ECO_0000203 NP707166.RAFVtgX2WTdSfkUiM0QssSJzkbkf9nm7-7K8RmHnP_Pgo130_provenance.